CompanyDeals

Triastek Inc. Secures $20.5 Million in Pre-Series C Financing for 3D Printing Pipeline

CompanyDrug

Tasly Pharmaceuticals Gets NMPA Approval for B1344 Clinical Study in NASH

CompanyDrug

ImmuneOnco Initiates Phase I Trial for CD24-Targeted Monoclonal Antibody IMM47

CompanyDeals

MitrAssist Lifesciences Secures $100 Million in Series C Financing for Cardiovascular Devices

CompanyDrug

Mabwell Bioscience Initiates Phase Ib/II Study for Nectin-4 Targeting ADC 9MW2821

CompanyDrug

LEO Pharma Initiates Phase III Clinical Trial for Delgocitinib in China

Policy / Regulatory

Beijing Insurance Bureau Launches Pilot to Boost Access to NRDL Drugs

Policy / Regulatory

Beijing-Tianjin-Hebei Region Initiates Drug VBP with 37 Medicines, Including Biologics

CompanyDeals

Regeneron Pharmaceuticals Acquires Decibel Therapeutics to Advance Hearing Loss Treatments

CompanyDeals

Novo Nordisk Partners with Valo Health to Develop Cardiometabolic Disease Therapies

CompanyDrug

Coherus Biosciences Awaits FDA Decision on Toripalimab with Year-End Approval Forecast

CompanyDrug

Cutia Therapeutics Files for Market Approval of CU-10201 with NMPA for Acne Treatment